Katie Wright, Author at European Medical Journal - Page 7 of 45

Steatotic Liver Disease Increases Risk of Atrial Fibrillation

This nationwide South Korean cohort study examined over six million young adults aged 20–39 years to assess new-onset AF according to contemporary SLD subtypes.

Faecal Microbiota Transplant Beats Antibiotics in Recurrent C. difficile

FMT and microbiome therapies significantly outperform antibiotics in recurrent C. difficile infection, with cure rates up to 91% and favourable long-term safety.

New AI System Boosts Accuracy in Skin Cancer Diagnosis

Clinical examination is limited by visual similarity between benign and malignant lesions and imperfect diagnostic accuracy.

Remote Management of Cystic Fibrosis with Wearable Sweat Sensor

Wireless sweat patch matches lab accuracy for cystic fibrosis monitoring, promising home-based disease management.

Trial Demonstrates Talazoparib Extends Prostate Cancer Survival

The TALAPRO-2 study enrolled 805 patients from 200 centres across 26 countries, including North America, Europe, Israel, South America, South Africa, and the Asia–Pacific region.

Obesity Limits Full Benefit of Asthma Biologics

A UK registry study shows asthma biologics improve outcomes across BMI groups, but obese patients remain more likely to have uncontrolled disease.

Digital Nursing Care Reduces Itching and Improves Sleep in AD

This study evaluated a clustered nursing care model, delivered via an online platform, for adults with atopic dermatitis.

Five-Minute Antibody Test Could Transform Hepatitis C Screening

Discover a study assessing whether a five-minute rapid antibody test can speed up hepatitis C diagnosis. Read on.

Synbiotic Tablet Restores Optimal Vaginal Microbiome

Researchers developed a novel vaginal synbiotic (VS-01) comprising three L. crispatus strains isolated from women with stable, optimal microbiomes.

Novel Salicylic Acid Gel Treats Acne While Protecting Skin

A recent study evaluated a novel 2% salicylic acid gel enriched with hydrating and soothing agents, aiming to balance acne treatment with skin barrier repair.